Abbott falls as it cuts 2026 sales growth view, plans to spin off nutrition business

Abbott Laboratories

21/10/2026 13:15

** Shares of Abbott ABT.N fall 3.88% to $98.47 premarket
** Co plans to separate its nutrition business into an independent, publicly traded company 
** ABT reduces its 2026 sales growth forecast
** Abbott now expects 2026 sales growth of about 6%, compared with its prior expectation of between 6.5% and 7.5%
     ** Separation is expected to be completed by the end of 2027
** Up to last close, stock down 18.23% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))